S. 839 · 112th Congress
Combating Designer Drugs Act of 2011
- Stage
- Reported from committee
- Sponsor
- Amy Klobuchar
- Introduced
- 2011-04-14
- Latest action
- 2011-07-28 · Committee on the Judiciary. Ordered to be reported without amendment favorably.
Summary
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Combating Designer Drugs Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains:
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E); 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D); 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2); 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H); 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); or 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).